Pricing Log in Create free account

LB Pharmaceuticals Inc (LBRX) vs Omeros Corporation (OMER)

LB Pharmaceuticals Inc and Omeros Corporation are both Biotechnology companies. LB Pharmaceuticals Inc and Omeros Corporation are of similar size ($1.2B and $1.2B). LB Pharmaceuticals Inc has negative trailing earnings, so its P/E is not meaningful; Omeros Corporation trades at 9.8×. Omeros Corporation has the higher net margin (128.4% vs 0.00%) and the higher return on invested capital (0.00% vs −1,304.8%). Across the 12 metrics below, Omeros Corporation leads on 7 and LB Pharmaceuticals Inc on 5.

Valuation

Metric LBRX OMER Biotechnology median
P/E n/m 9.84 10.60
P/S n/m 12.48 9.40
P/B 3.81 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 12.30 9.02
Earnings yield (8.19%) 10.16% (32.88%)
Free cash flow yield (6.54%) (5.66%) (23.13%)

Profitability

Metric LBRX OMER Biotechnology median
Gross margin — 37.57% 68.51%
Operating margin 0.00% (74.88%) 0.00%
Net margin 0.00% 128.36% 0.00%
Free cash flow margin 0.00% (70.69%) 0.00%
Return on equity (72.07%) (89.15%) (51.96%)
Return on assets (47.38%) 51.22% (46.06%)
Return on invested capital (1,304.79%) 0.00% 0.00%

Growth

Metric LBRX OMER Biotechnology median
Revenue growth (TTM) — 36.32% 6.76%
EPS growth (last fiscal year) 98.22% 98.15% 29.88%
Revenue growth, 5-year CAGR — 40.44% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LBRX OMER Biotechnology median
Debt to equity 0.00 (1.89) 0.00
Current ratio 15.08 1.95 4.97
Net debt to EBITDA 9.90 (0.30) 1.01

Dividend

Metric LBRX OMER Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LBRX OMER Biotechnology median
Market cap 1.23b 1.24b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack